March 2 (Reuters) — Merck & Co. Inc. will help make rival Johnson & Johnson's single-shot COVID-19 vaccine, the Washington Post reported on Tuesday, citing senior officials from the Biden administration.

President Joe Biden is expected to make the announcement on Tuesday, the report said. U.S-based Merck halted the development of two of its own coronavirus vaccines in January to instead focus on its two COVID-19 treatments.

The company said last month that it was in talks with governments and companies to potentially help with manufacturing of COVID-19 vaccines that have been authorized.

The drugmaker will dedicate two U.S. facilities to Johnson & Johnson's vaccine, according to the report.

"Merck remains steadfast in our commitment to contribute to the global response to the pandemic," the company said.

WDAY logo
listen live
watch live
Newsletter signup for email alerts

J&J did not immediately respond to a Reuters request for comment.

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)